TRT on TikTok: separating testosterone facts from bro-science

What did @its.reigning.ben actually say?

The creator describes two testosterone readings, 205 ng/dL and 264 ng/dL, taken before starting TRT. His primary care doctor told him 264 was "in the normal range" and declined a referral. The creator pushed back, arguing that 264 is not normal for a 28-year-old, eventually securing an endocrinology referral. He now reports feeling best with levels around "75 to 800" (presumably 750-800) ng/dL mid-cycle, and felt worse at nearly 1,000 ng/dL, describing acne as a notable side effect at that level.

He also criticizes his primary care physician for not recognizing age-appropriate reference ranges, which is a legitimate grievance worth examining on its own terms.

Does the science back this up?

Mostly, yes. The argument that 264 ng/dL is clinically low for a 28-year-old has real support in the literature, even if the exact cutoffs are debated.

The Endocrine Society's clinical practice guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) define hypogonadism as a total testosterone consistently below 300 ng/dL, paired with symptoms. At 264, the creator was below that threshold on his first draw. At 205, he was well below it. The repeat test at 264 is borderline by the Society's own numbers, not a clean bill of health.

Age matters here too. Testosterone peaks in the early-to-mid twenties and declines gradually after that, roughly 1-2% per year (Harman et al., 2001, Journal of Clinical Endocrinology and Metabolism). A 28-year-old with levels typical of a 70-year-old warrants a clinical conversation, not dismissal. The creator's frustration is medically defensible.

What did they get wrong (or right)?

He got the core argument right. Where things get murkier is the framing around his current levels and how he describes the treatment experience.

Calling 750-800 ng/dL his "sweet spot" mid-cycle is plausible within the physiological range, but "mid-cycle" testing on TRT with injections tends to capture a peak or near-peak, not a trough. Trough levels matter clinically. Reporting only mid-cycle numbers without context can paint an incomplete picture of what his actual hormone exposure looks like across a full dosing interval.

His observation that nearly 1,000 ng/dL caused acne and felt worse is actually consistent with the literature. Supraphysiological testosterone increases sebum production via androgen receptor activity in sebaceous glands (Fritsch et al., 2001, Dermatology). Dialing back was the right call, and credit goes to him for recognizing symptoms and working with his provider to adjust.

The claim that his doctor's lab system lists 220 ng/dL as the lower bound of normal is unusual. Most major lab reference ranges set the floor closer to 264-300 ng/dL for adult men. If his system truly listed 220, that is an outlier worth questioning.

What should you actually know?

A single testosterone reading is rarely enough to make a diagnosis, which is why repeat testing is standard practice. Both of the creator's readings were below 300 ng/dL, which meets the biochemical threshold the Endocrine Society uses as a starting point for further workup, especially when symptoms are present.

Symptoms matter as much as numbers. The FDA-approved indication for TRT is symptomatic hypogonadism confirmed by lab values, not lab values alone. If someone has a testosterone of 250 and no symptoms, the calculus is different than for someone with fatigue, low libido, and mood changes at the same level.

Primary care physicians vary significantly in how they interpret testosterone panels. A 2020 survey published in Urology found that many PCPs use lab reference ranges rather than clinical guidelines to define low testosterone, which can result in patients with biochemically low levels being told they are fine. The creator ran into exactly this scenario, and it is more common than it should be.

Finally, self-reported "feeling great" is real data, but it is not a substitute for comprehensive follow-up labs including hematocrit, PSA (even in younger men on TRT), and lipids. Long-term TRT monitoring requires more than a testosterone level every six months.